Hicin Pharmaceutical(SZ:300584) Xin Lang Cai Jing·2025-08-23 01:37Core Insights - Hai Chen Pharmaceutical (300584.SZ) released its semi-annual report for 2025 on August 23, 2025, indicating a total of 6 institutional investors holding shares, amounting to 3.3137 million shares, which represents 2.76% of the total share capital [1] - The institutional investors include UBS AG, MORGAN STANLEY & CO. INTERNATIONAL PLC, Goldman Sachs International - proprietary funds, BARCLAYS BANK PLC, China International Capital Corporation, and J.P. Morgan Securities PLC - proprietary funds, with a total institutional holding ratio increase of 1.61 percentage points compared to the previous quarter [1] - In terms of foreign investment, there was no new disclosure of foreign institutions compared to the previous quarter, specifically mentioning MORGAN STANLEY & CO. INTERNATIONAL PLC [1]